Abstract

Cervical cancer (CC) is the most common gynecological malignancy, whose cellular heterogeneity has not been fully understood. Here, we performed single-cell RNA sequencing (scRNA-seq) to survey the transcriptomes of 57,669 cells derived from three CC tumors with paired normal adjacent non-tumor (NAT) samples. Single-cell transcriptomics analysis revealed extensive heterogeneity in malignant cells of human CCs, wherein epithelial subpopulation exhibited different genomic and transcriptomic signatures. We also identified cancer-associated fibroblasts (CAFs) that may promote tumor progression of CC, and further distinguished inflammatory CAF (iCAF) and myofibroblastic CAF (myCAF). CD8+ T cell diversity revealed both proliferative (MKI67+) and non-cycling exhausted (PDCD1+) subpopulations at the end of the trajectory path. We used the epithelial signature genes derived from scRNA-seq to deconvolute bulk RNA-seq data of CC, identifying four different CC subtypes, namely hypoxia (S-H subtype), proliferation (S-P subtype), differentiation (S-D subtype), and immunoactive (S-I subtype) subtype. The S-H subtype showed the worst prognosis, while CC patients of the S-I subtype had the longest overall survival time. Our results lay the foundation for precision prognostic and therapeutic stratification of CC.

Single-cell RNA sequencing of cervical cancer reveals four different cancer subtypes and provides information on populations of cancer-associated fibroblasts as well as CD8+ T cell diversity.

Details

Title
Single-cell transcriptomics reveals cellular heterogeneity and molecular stratification of cervical cancer
Author
Li, Chunbo 1 ; Wu, Hao 2 ; Guo, Luopei 1 ; Liu, Danyang 3 ; Yang, Shimin 1 ; Li, Shengli 4   VIAFID ORCID Logo  ; Hua, Keqin 1   VIAFID ORCID Logo 

 Obstetrics and Gynecology Hospital of Fudan University, Department of Obstetrics and Gynecology, Shanghai, China (GRID:grid.412312.7) (ISNI:0000 0004 1755 1415) 
 Shanghai Jiao Tong University School of Medicine, Precision Research Center for Refractory Diseases, Institute for Clinical Research, Shanghai General Hospital, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293); Shanghai University, Laboratory of Molecular Neural Biology, School of Life Sciences, Shanghai, China (GRID:grid.39436.3b) (ISNI:0000 0001 2323 5732) 
 Obstetrics and Gynecology Hospital of Fudan University, Department of Pathology, Shanghai, China (GRID:grid.412312.7) (ISNI:0000 0004 1755 1415) 
 Shanghai Jiao Tong University School of Medicine, Precision Research Center for Refractory Diseases, Institute for Clinical Research, Shanghai General Hospital, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2734874101
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.